William Lewis Transaction History

Date Transaction Value Shares Traded Form
Dec 19 2024
SELL
Open market or private sale
$479,192 $70.16 p/Share
6,830
Dec 19 2024
BUY
Exercise of conversion of derivative security
$74,105 $10.85 p/Share
6,830
Dec 12 2024
SELL
Open market or private sale
$501,663 $73.45 p/Share
6,830
Dec 12 2024
BUY
Exercise of conversion of derivative security
$74,105 $10.85 p/Share
6,830
Feb 28 2024
BUY
Exercise of conversion of derivative security
$629,000 $12.58 p/Share
50,000
Oct 27 2023
SELL
Open market or private sale
$2,804,480 $25.04 p/Share
112,000
Oct 27 2023
BUY
Exercise of conversion of derivative security
$1,602,000 $14.24 p/Share
112,500
May 12 2023
BUY
Exercise of conversion of derivative security
$2,910,014 $12.44 p/Share
233,924
Aug 08 2022
SELL
Open market or private sale
$6,087,744 $28.08 p/Share
216,800
Aug 08 2022
BUY
Exercise of conversion of derivative security
$862,864 $3.98 p/Share
216,800

Also insider at

NAMS
NewAmsterdam Pharma Co N.V.
WL

William Lewis

Chair and CEO
Bridgewater, NJ

Track Institutional and Insider Activities on INSM

Follow INSMED Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

News

Receive news related to INSMED Inc

Track Activities on INSM